FDA Adverse Event Malfunction Summary report: N

REFLEXION

MDR report key: 22149925 · Received June 5, 2025

Report

Report Number
MW5171095
Event Type
Malfunction
Date Received
June 5, 2025
Report Date
May 29, 2025
Manufacturer
REFLEXION MEDICAL, INC.
Product Code
QVA
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
OR, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
*

Narratives

Description of Event or Problem · 0

THREE (3) PATIENTS WITH PROSTATE CANCER REPORTED A FEELING OF WARMTH DURING TREATMENT AND SEVERE SIDE EFFECTS INCLUDING URINARY FREQUENCY AND OTHER URINARY SYMPTOMS. REF REPORTS: MW5171096 AND MW5171097.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1401584 REFLEXION FLUDEOXYGLUCOSE F18-GUIDED RADIATION THERAPY SYSTEM QVA REFLEXION MEDICAL, INC. RX1

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown